
(213) 319-3339Dermatologist in Downtown LA
LaseMD Ultra is a nonablative fractional laser that creates a controlled pattern of microscopic treatment zones while leaving the surrounding skin intact. It can be used for pigmentation, sun damage, uneven tone, texture, and overall skin quality.
FDA-cleared for sun spots, age spots, freckles, and actinic keratoses (510(k) K192331). Texture, melasma, and hair growth are not cleared uses. The clearance names no skin types, so your provider assesses yours.

Reviews across our five offices. Read patient reviews
LaseMD Ultra is available at our Downtown LA, Brentwood, Pasadena, and San Jose offices.
Your plan and cost are set at your consultationThe LaseMD Ultra is a thulium laser made by Lutronic, now part of Cynosure Lutronic. It has one treatment wavelength, 1927 nm, and up to 20 watts of power, delivered through a fiber to a handpiece.
No FDA clearance carries the name "LaseMD Ultra". The FDA cleared the laser in November 2019 under the name LaseMD LEO (510(k) K192331), and the FDA's device listing records the name LaseMD Ultra under that same clearance. The original, lower-power LaseMD was cleared in June 2017 (K171009) for the same uses.
We are reading the label on each of our units to confirm whether it is the LaseMD Ultra or the original LaseMD. Both carry the same FDA-cleared uses, so what this page says about clearance applies either way.
Patients also search for it as Lase MD Ultra, Laser MD Ultra, UltraLase MD, or the Lutronic Ultra laser. This page is about the Lutronic LaseMD Ultra.
The LaseMD Ultra is available near you at our Downtown Los Angeles, Brentwood, Pasadena, and San Jose offices. Our Costa Mesa office in Orange County does not offer it; ask our team there about other lasers.
| Name on the FDA clearance | Name it is listed and sold under | Power | 510(k) and date |
|---|---|---|---|
| LaseMD LEO Laser System | LaseMD Ultra | Up to 20 W | K192331, 12 November 2019 |
| LASEMD Laser System | LaseMD | 5 W | K171009, 23 June 2017 |
Both records carry the same cleared uses, word for word. A 1927 nm laser from another maker (K252732) is a different device.
The 1927 nm beam is absorbed by water in the skin more strongly than the beams of most nonablative fractional lasers, so its effect stays mainly in the outer skin and the upper layer just beneath it.
The laser heats a pattern of microscopic zones and leaves the skin between them intact. The FDA summary describes its action as thermal coagulation, with power kept below the level that removes tissue.
A fiber carries the beam to a handpiece with interchangeable tips. Some tips roll across the skin and others stamp a fixed area, with spot sizes of 200 or 350 microns.
We select the technology, wavelength, depth, and settings based on your skin rather than asking your skin to fit a particular device. In a small 2025 imaging study of the LaseMD, higher pulse energies spread the heat wider and deeper, and the highest settings began to remove tissue at the surface.
Lasers are FDA-cleared, not FDA-approved: the FDA found each device equivalent to one already on the market, for the specific uses named in its clearance.
The cleared wording for the LaseMD Ultra (K192331, 12 November 2019) reads: "indicated for use in dermatological procedures requiring the coagulation of soft tissue, treatment of actinic keratosis, and treatment of benign pigmented lesions such as, but not limited to lentigos (age spots), solar lentigos (sunspots) and ephelides (freckles)."
| Use | What it is for | FDA clearance |
|---|---|---|
| Sun spots, age spots, and freckles | Flat brown spots from sun exposure, once a dermatologist confirms they are harmless | Cleared, as benign pigmented lesions |
| Actinic keratoses | Rough, scaly spots from sun damage; treating them can reduce the risk of skin cancer | Cleared |
| Uneven tone, texture, and skin quality | Fractional treatment for sun damage, uneven tone, texture, and overall skin quality | Not a cleared use. Texture and overall skin quality are not named in the clearance |
| Melasma | Brown patches on the cheeks, forehead, or upper lip | Not a cleared use. Lasers can make melasma worse |
| Thinning hair (KeraLase) | The laser paired with a scalp serum | Not a cleared use. No FDA clearance or approval found for KeraLase |
Uses outside a clearance are a medical decision your dermatologist explains before treatment. "Provider assesses" means no clearance or study states a range for this laser, so your provider decides with you.
KeraLase combines the LaseMD Ultra laser with a topical scalp serum. The laser creates controlled microchannels in the scalp before the serum is applied. Keralase MD
Skin type is one of the first considerations in any laser treatment, not a footnote. Different wavelengths and technologies interact with pigment, blood vessels, water, and tissue in different ways. The device matters, but so do the settings, technique, and experience of the person using it.
If the treatment you requested is not appropriate for your skin, we will explain why and recommend a safer or more effective alternative.
The LaseMD clearances name no skin types. Small studies of other makers' 1927 nm lasers included skin types II to IV, and darker skin is more prone to burns and dark marks after laser treatments. The energy and density of treatment drive the risk of dark marks, so your provider sets both for your skin.
The right treatment is not automatically the strongest one. Technology provides options. Knowing which device to use, and how to use it, is what makes those options meaningful.
| Device | What it is used for | Recovery |
|---|---|---|
| LaseMD Ultra | Pigmentation, sun damage, uneven tone, texture, and overall skin quality | Shorter than ablative resurfacing; varies with intensity |
| Hollywood Spectra | Pigment, tone, tattoos, and the carbon laser facial | Low for the carbon facial; varies by use |
| Spectra MDF | Fractional treatment for texture, scars, pores, and uneven tone | Less than ablative CO2 resurfacing |
| UltraClear (Costa Mesa) | Pigmentation, uneven tone, texture, wrinkles, scars, and deeper resurfacing, at different depths | Adjusted with the degree of treatment |
| eCO2 and EdgeOne | Deeper texture irregularities, acne scars, wrinkles, and sun damage | Often a week or longer |
| Chemical peels | Texture, pores, melasma, dark marks, and acne, without a device | Depends on the strength of the peel |
For how these lasers compare by downtime, see laser skin resurfacing. All our technology. For redness and vessels, see DermaV.
| Effect | What to know |
|---|---|
| Redness and swelling | Expected after treatment, and longer with stronger settings. In a study of another 1927 nm laser, swelling eased within a day and redness within a week. |
| Dryness and flaking | Some patients have dry, flaking skin as it heals. |
| Dark marks or light spots | Pigment changes are among the most common lasting complications of laser treatment. Darker skin is more prone to dark marks, and the energy and density chosen drive the risk. |
| Melasma flaring | A 2026 report from one clinic linked a 1927 nm laser from another maker with melasma flaring, or appearing for the first time, in some women with medium skin tones, often more than a year later. |
| Cold sores | Laser treatment can reactivate cold sores. If you get them, preventive medicine is recommended before treatment. |
| Infection | Any break in the skin barrier can let infection in, which is why aftercare matters. |
| Scarring | One of the most serious late complications of laser treatment in general. |
A 1927 nm thulium laser made by Lutronic, now part of Cynosure Lutronic. LaseMD Ultra is a nonablative fractional laser that creates a controlled pattern of microscopic treatment zones while leaving the surrounding skin intact.
Yes, cleared rather than approved. The FDA cleared it in November 2019 under the name LaseMD LEO (510(k) K192331) for coagulation of soft tissue, actinic keratosis, and benign pigmented lesions such as age spots, sunspots, and freckles. The FDA's device listing records the name LaseMD Ultra under that clearance.
The clearance was filed under the name LaseMD LEO Laser System. The FDA's device listing shows the laser sold as LaseMD Ultra under that same clearance number, K192331.
They share the same 1927 nm thulium wavelength and the same cleared uses. The LaseMD Ultra (LaseMD LEO) reaches up to 20 W of power; the original LaseMD, cleared in 2017, is listed at 5 W. We are confirming which model each of our offices has.
It is designed as a nonablative laser: the FDA summary describes heating below the level that removes tissue. In a small 2025 imaging study of the LaseMD, the highest energy settings began to remove tissue at the surface, so the energy your provider chooses shapes how gentle the treatment is.
Melasma is not a cleared use, and lasers can make melasma worse. Melasma is especially sensitive to heat and inflammation. An overly aggressive treatment can trigger rebound pigmentation and leave the skin darker than before. We treat melasma conservatively, and creams and sun protection come first. Melasma laser
Texture and overall skin quality are not named in its FDA clearance. It can be used for pigmentation, sun damage, uneven tone, texture, and overall skin quality, and recovery is generally shorter than with ablative resurfacing. Laser skin resurfacing
KeraLase combines the LaseMD Ultra laser with a topical scalp serum, and it is typically paired with other hair treatments. Hair growth is not a cleared use of the laser, and we found no FDA clearance or approval for KeraLase or its serum (checked 8 November 2026). Laser hair restoration
It depends on what we are treating. Treatment is usually a series, and one study of another 1927 nm laser used three treatments about a month apart. Your provider sets the number and spacing at your consultation.
Recovery is generally shorter than with ablative resurfacing, although redness and sensitivity vary with treatment intensity and individual skin response. At lighter settings, redness typically settles within a day; stronger treatments can bring redness and swelling for several days.
The FDA clearance names no skin types, so your provider assesses your skin. Small studies of other makers' 1927 nm lasers included skin types II to IV. Darker skin is more prone to burns and dark marks after laser treatments, and the energy and density used drive that risk, so we set both for your skin.
Downtown LA, Brentwood, Pasadena, and San Jose. Our Costa Mesa office in Orange County does not offer it; ask our team there about other lasers.
Plans and costs are set at your consultation, once we know what you want to change and which treatments fit. Insurance is accepted for eligible medical care; health insurance generally does not cover cosmetic treatments.
Sources: FDA 510(k) clearances for the LaseMD LEO (K192331) and the LASEMD (K171009); American Academy of Dermatology on skin conditions lasers treat and actinic keratosis treatment; Wenande and colleagues, 2025; Li and colleagues, 2023; Cancel-Artau and colleagues, 2026; Nguyen and colleagues, 2026.
LaseMD Ultra is available at four of our five offices.




Our Costa Mesa office does not offer LaseMD Ultra; ask about other lasers there. What patients say.
6 dermatologists, 7 physician assistants and nurse practitioners. Providers, schedules, and treatment availability vary by location and may change over time.













No providers listed for this office yet. See the full team.
Share what is happening with your skin and where you would like to go from here. We will help match you with the right provider and type of visit.